MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25675938.
- Also identified by DOI 10.1002/ana.24384.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently, we reported downregulated circulating levels of the microRNAs miR-19b, miR-29a, and miR-29c in Parkinson disease. Here we investigated the expression of these microRNAs in serum samples from 56 patients with idiopathic rapid eye movement sleep behavior disorder, before and after their conversion into a synucleinopathy. Compared to controls, we found that the expression level of miR-19b is downregulated in patients with idiopathic rapid eye movement sleep behavior disorder and antedates the diagnosis of Parkinson disease and dementia with Lewy bodies after 4.67 ± 2.61 years of follow-up. Our findings indicate that dysregulation of the microRNA miR-19b occurs in the prodromal stage of synucleinopathies.
Medical subject headings
- Disease Progression
- MicroRNAs
- REM Sleep Behavior Disorder
- Synucleins